CONCERT PHARMACEUTICALS INC's ticker is CNCE and the CUSIP is 206022105. A total of 91 filers reported holding CONCERT PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 3.11 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $265,000 | -84.5% | 15,764 | -78.9% | 0.00% | -100.0% |
| Q1 2018 | $1,714,000 | -11.5% | 74,839 | 0.0% | 0.00% | -33.3% |
| Q4 2017 | $1,936,000 | +75.4% | 74,839 | 0.0% | 0.00% | +50.0% |
| Q3 2017 | $1,104,000 | +5.7% | 74,839 | 0.0% | 0.00% | 0.0% |
| Q2 2017 | $1,044,000 | +37.9% | 74,839 | +68.7% | 0.00% | +100.0% |
| Q1 2017 | $757,000 | +103.5% | 44,363 | +22.7% | 0.00% | 0.0% |
| Q4 2016 | $372,000 | +1.6% | 36,163 | 0.0% | 0.00% | 0.0% |
| Q3 2016 | $366,000 | -45.3% | 36,163 | -35.3% | 0.00% | 0.0% |
| Q2 2016 | $669,000 | -11.9% | 55,934 | 0.0% | 0.00% | 0.0% |
| Q1 2016 | $759,000 | -28.5% | 55,934 | 0.0% | 0.00% | -50.0% |
| Q4 2015 | $1,061,000 | +1.0% | 55,934 | 0.0% | 0.00% | 0.0% |
| Q3 2015 | $1,050,000 | – | 55,934 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BVF INC/IL | 2,253,000 | $7,097,000 | 0.26% |
| INGALLS & SNYDER LLC | 1,358,573 | $4,280,000 | 0.19% |
| RA Capital Management | 3,033,603 | $9,556,000 | 0.17% |
| Kensington Investment Counsel, LLC | 85,483 | $269,000 | 0.16% |
| Perceptive Advisors | 4,301,282 | $13,548,000 | 0.10% |
| NewEdge Wealth, LLC | 381,326 | $1,201,000 | 0.05% |
| Black Diamond Financial, LLC | 46,000 | $145,000 | 0.05% |
| Birchview Capital, LP | 20,000 | $63,000 | 0.04% |
| XTX Topco Ltd | 14,305 | $45,000 | 0.02% |
| Alyeska Investment Group, L.P. | 548,090 | $1,726,000 | 0.02% |